Yoshika Sherring


Senior biotechnology marketing and business development professional with 18 years experience in the global biopharmaceutical industry.Expertise in the identification and execution of commercial and business development strategies for emerging and multinational life science companies. Successful track record in the development and implementation of global marketing initiatives for early clinical-stage and marketed products. 

  • Championed commercial pre-launch activities for clinical-stage biopharmaceutical company with focus in oncology.
  • Developed and executed strategic marketing plans, global brand vision, and competitive strategies for a range of companies encompassing small to Fortune 500.
  • Led business development activities by managing due diligence teams and performing deep-dive analysis on potential partners and technologies.
  • Built and maintained strong relationships with global key opinion leaders, patient advocacy groups and patients.

Work History

Work History
2006 - 2008

Senior Director, Commercial Development

Molecular Insight Pharmaceuticals

Developed & led the commercial vision for orphan oncology candidates in phase II to ensure “launch readiness”.

·Branding – Developed U.S. and E.U. brand elements including positioning, targeted messaging, logo, and taglines that resulted in the final brand for Azedra™ (phase 2 candidate for Pheochromocytoma and Neuroblastoma), ahead of schedule.

·Medical Education – Managed and worked closely with Agency resulting in the following:

▪ 2 comprehensive Publication Plans - (a) Azedra™ and (b) Zemiva™ (for cardiology), to be used as a roadmap through 2010.

▪ 5 Continuing Medical Education Symposia

▪ 8 Executive Advisory Boards comprised of Key Opinion Leaders (4 oncology & 4 cardiology)

▪ Slide kit for Medical Science Liaison use

·Patient Advocacy - Developed “full-partnerships” with 3 oncology focused patient advocacy groups. Molecular Insight was featured in multiple outreach programs resulting in increased awareness of Azedra™.

·KOL development - built relationships and brought market insight to the product development team.

·Coordinated strategic planning process for Sales Force development and Medical Science Liaisons.

·Worked on comprehensive marketing plan for rapidly increasing patient enrollment in phase 2a clinical trial for Azedra™, under a Special Protocol Assessment, with Fast Track Designation, and Orphan Drug Status.

·Developed forecasts and pricing models for the United States & Europe.

·Directed the development and approval of all marketing collateral used at International congresses.

·Lead due diligence on 10 portfolio expansion opportunities leading to multiple licensing transactions, most notably with Novartis for Onalta™ (Carcinoid), and Bayer Schering for Solazed™ (Melanoma).

  • Promoted from Director to Senior Director in July 2008.
2003 - 2006

Founder & President

Arrow Nuclear Strategies, Inc.

A biotech consulting firm dedicated to helping clients globally achieve revenue objectives by defining marketing strategies, and identifying and evaluating business development opportunities.

  • Worked with multinational clients on a broad range of needs related to product strategy. Deliverables included market research, product launches, development of marketing collateral, pricing, and forecasts.
  • Interfaced with outside marketing agencies to develop company identity, management of tradeshow logistics and corporate communications functions.
  • Tracked market trends and updated clients on a monthly basis. Conducted market research on opportunities being evaluated by client and presented data to Senior Management.
1998 - 2003

Senior Global Product Manager

PerkinElmer Life Sciences

Managed the global Radiotherapeutics business that included active pharmaceutical ingredients for cancer therapies.  Developed & drove strategic marketing initiatives to meet forecasted revenue goals and evaluated global business development opportunities.  Managed associates both in the United States & Europe. 

  • Developed marketing plans and worked closely with the global sales organization to double revenue of Radiotherapeutics business between December 1999 and 2001.
  • Managed product launch activities including management of cross-functional team, conducting market research, and developing pricing and forecast models.
  • Closely supported corporate communications goals by working on website content, writing press releases, developing corporate presentations, and writing content for select journal ads.
  • Grew product lines by ten to fifteen percent year over year. Worked closely with field sales, developed global marketing and pricing strategies, initiated new product development, and launched products into the marketplace.
  • Promoted from Global Product Manager to Senior Global Product Manager in 2000.
1997 - 1998

Business Development Manager

Creative BioMolecules
  • Targeted pharmaceutical companies to explore partnering opportunities. Analyzed potential partners and worked on developing term sheets.
1995 - 1997

Product Marketing Manager

Schleicher & Schuell (now Whatman)
  • Launched new products into target market segments, developed strategic and tactical marketing plans, set the pricing structure, forecasted, and developed on-going training for field sales. Managed the company's flagship product line and maintained ninety percent market share.
1992 - 1995

Senior Research Assistant

Therion Biologics
  • Aided the development of recombinant vaccines by genetically engineering virus systems at the molecular level. Part-time role as Business Development Manager, managing technology licenses while working on M.B.A.
1990 - 1992

Assistant Research Scientist

Abbott Biotech
  • Aided the development of recombinant vaccines by genetically engineering virus systems at the molecular level. Part-time role as Business Development Manager, managing technology licenses while working on M.B.A.


1991 - 1995


Bentley College

Portfolio Samples